Retatrutide 30mg (5-Vials Bundle)

Triple Incretin Receptor Agonist | GLP-1 + GIP + Glucagon for Advanced Fat Loss & Metabolic Optimization

Overview:

Retatrutide is a next-generation triple incretin agonist, targeting GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and Glucagon receptors simultaneously. This unique triple-action mechanism offers a powerful blend of appetite suppression, fat oxidation, and energy regulation, positioning Retatrutide at the forefront of advanced weight management and metabolic enhancement therapies.

This product is supplied as a lyophilized powder and requires reconstitution before use.

*Bundled vials do not always come labeled. Subject to availability*

Retatrutide delivers a more comprehensive metabolic approach by activating three complementary hormonal pathways rather than one or two.

Its compounded effects on appetite control, lipid metabolism, and energy expenditure make it an ideal option for high-response fat-loss protocols and advanced body recomposition strategies, particularly at higher-capacity kit strengths.

• Promotes deep, sustained fat loss through increased metabolic rate

• Strong appetite and craving suppression

• Enhances insulin sensitivity and glycemic control

• Supports lipid metabolism and energy balance

• Once-weekly subcutaneous dosing for convenience